Table 3. Treatment characteristics of sexual violence survivors presenting for care in Masisi (conflict zone) and Niangara (post-conflict zone), Democratic Republic of Congo, 2012.

	Masisi		Niangara
	N	%	N	%	p-value*
Follow-up**					<0.0001
First return visit	239/491	49%	109/180	61%
Second return visit	137/491	28%	68/178	38%
Third return visit	51/462	11%	35/155	23%
Fourth return visit	15/354	4%	13/109	12%
HIV testing at first contact					<0.0001***
Turned down	7	1%	5	3%
Test not available	292	60%	44	25%
Status already known	1	0.2%	2	1%
Postponed to a later date	9	2%	106	59%
Consented to testing	181	37%	21	12%
Not documented	1	0.2%	2	1%
HIV testing at any visit	211	43%	38	21%	0.7***
Positive	4	2%	1	3%
Negative	207	98%	37	97%
PEP Prophylaxis
Eligible (all survivors of rape presenting within 72 h)	288	59%	51	29%	<0.0001
Started (out of eligible)	284	99%	51	100%	0.4
Completed (out of started)	56	20%	20	39%	0.002
STI Prophylaxis
Eligible (all survivors of rape)	483	98%	172	96%	0.03
Started (out of eligible)	480	99%	164	95%	0.0004
Emergency Contraception
Eligible (all female survivors of rape age 12–45 presenting within 5 days)	274	56%	53	29%	<0.0001
Started (out of eligible)	250	91%	46	87%	0.3
Pregnancy test
Eligible (all female patients age 12–45)	424	86%	148	82%	0.2
Test done (out of eligible)	408	96%	130	88%	0.0002
Test positive (out of done)	18	4%	19	15%	0.0001
Abortion requested (out of pregnant)	2/18	17%	12	63%	0.01
Abortion done (out of requested)	0	0	9	75%	0.05
Tetanus vaccination
TT1	334	68%	138	77%	0.03
TT2 (out of TT1)	59	18%	36	26%	0.04
Hepatatis B vaccination
HepB1	266	54%	142	79%	<0.0001
HepB2 (out of HepB1)	161	61%	83	59%	0.7

*Chi-square test for proportions; **Follow-up completion was assessed at 7 days (visit 1), 28 days (visit 2), 3 months (visit 3), and 6 months (visit 4); denominators are the number of patients who were eligible for these follow-up visits; ***Chi-square test with Yates’ correction.

PEP: Post-Exposure Prophylaxis; STI: Sexually Transmitted Infection.